130 related articles for article (PubMed ID: 24652962)
1. Desmopressin and super platelets.
Pecci A; Balduini CL
Blood; 2014 Mar; 123(12):1779-80. PubMed ID: 24652962
[No Abstract] [Full Text] [Related]
2. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
Colucci G; Stutz M; Rochat S; Conte T; Pavicic M; Reusser M; Giabbani E; Huynh A; Thürlemann C; Keller P; Alberio L
Blood; 2014 Mar; 123(12):1905-16. PubMed ID: 24443440
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
[TBL] [Abstract][Full Text] [Related]
4. Hermansky-Pudlak syndrome: correction of bleeding time by 1-desamino-8D-arginine vasopressin.
Wijermans PW; van Dorp DB
Am J Hematol; 1989 Mar; 30(3):154-7. PubMed ID: 2916560
[TBL] [Abstract][Full Text] [Related]
5. 1-Deamino-8-D-arginine vasopressin (DDAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypass.
Sloand EM; Alyono D; Klein HG; Chang P; Yu M; Lightfoot FG; Kessler C
Am J Hematol; 1994 Jul; 46(3):199-207. PubMed ID: 8192149
[TBL] [Abstract][Full Text] [Related]
6. Consistency of responses to separate desmopressin infusions in patients with storage pool disease and isolated prolonged bleeding time.
Castaman G; Rodeghiero F
Thromb Res; 1993 Feb; 69(4):407-12. PubMed ID: 8470063
[No Abstract] [Full Text] [Related]
7. Desmopressin induces decrease in platelet serotonin content in uremia.
Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
[No Abstract] [Full Text] [Related]
8. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
[TBL] [Abstract][Full Text] [Related]
9. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
Pfueller SL; Howard MA; White JG; Menon C; Berry EW
Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
11. [From platelet functions to therapy].
Jandrot-Perrus M; Nurden P
Rev Med Interne; 2010 Dec; 31 Suppl 3():S319-23. PubMed ID: 21056518
[No Abstract] [Full Text] [Related]
12. [Application of DDAVP for hemostatic control in platelet dysfunctions].
Hattori A
Rinsho Ketsueki; 1990 Jan; 31(1):1-9. PubMed ID: 2179599
[No Abstract] [Full Text] [Related]
13. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
Wun T; Paglieroni TG; Lachant NA
J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin in the treatment of patients with defects of platelet function.
Cattaneo M
Haematologica; 2002 Nov; 87(11):1122-4. PubMed ID: 12414337
[No Abstract] [Full Text] [Related]
15. DDAVP shortens the bleeding time in Bernard-Soulier syndrome.
Cuthbert RJ; Watson HH; Handa SI; Abbott I; Ludlam CA
Thromb Res; 1988 Mar; 49(6):649-50. PubMed ID: 3388316
[No Abstract] [Full Text] [Related]
16. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin for the treatment of aspirin-induced platelet dysfunction.
Schulz-Stübner S
Neurocrit Care; 2011 Feb; 14(1):148. PubMed ID: 20717749
[No Abstract] [Full Text] [Related]
18. A practical concept for preoperative management of patients with impaired primary hemostasis.
Koscielny J; von Tempelhoff GF; Ziemer S; Radtke H; Schmutzler M; Sinha P; Salama A; Kiesewetter H; Latza R
Clin Appl Thromb Hemost; 2004 Apr; 10(2):155-66. PubMed ID: 15094936
[TBL] [Abstract][Full Text] [Related]
19. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
Yang X; Disa J; Rao AK
Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
